|
J Biol Chem, Vol. 274, Issue 49, 35191-35195, December 3, 1999
Annexin VI Participates in the Formation of a Reversible,
Membrane-Cytoskeleton Complex in Smooth Muscle Cells*
Eduard B.
Babiychuk §,
Robert-Jan T. S.
Palstra ¶,
Johann
Schaller ,
Urs
Kämpfer , and
Annette
Draeger **
From the Institute of Anatomy, University of Bern,
3012 Bern, Switzerland, the § Institute of Physiology, Kiev
University, 252031 Kiev, Ukraine, and the Institute of
Biochemistry, University of Bern, 3012 Bern, Switzerland
 |
ABSTRACT |
The plasmalemma of smooth muscle cells is
periodically banded. This arrangement ensures efficient transmission of
contractile activity, via the firm, actin-anchoring regions, while the
more elastic caveolae-containing "hinge" regions facilitate rapid
cellular adaptation to changes in cell length. Since cellular mechanics are undoubtedly regulated by components of the membrane and
cytoskeleton, we have investigated the potential role played by
annexins (a family of phospholipid- and actin-binding,
Ca2+-regulated proteins) in regulating sarcolemmal
organization. Stimulation of smooth muscle cells elicited a relocation
of annexin VI from the cytoplasm to the plasmalemma. In smooth, but not
in striated muscle extracts, annexins II and VI coprecipitated with
actomyosin and the caveolar fraction of the sarcolemma at elevated
Ca2+ concentrations. Recombination of actomyosin, annexins,
and caveolar lipids in the presence of Ca2+ led to
formation of a structured precipitate. Participation of all 3 components was required, indicating that a
Ca2+-dependent, cytoskeleton-membrane complex
had been generated. This association, which occurred at physiological
Ca2+ concentrations, corroborates our biochemical
fractionation and immunohistochemical findings and suggests that
annexins play a role in regulating sarcolemmal organization during
smooth muscle contraction.
 |
INTRODUCTION |
The unique role of smooth muscle cells residing within any organ
wall is their propulsive activity. Irrespective whether they belong to
the gastrointestinal, the urogenital tract, or the vascular system,
their contraction exerts a force, which is transmitted along their
entire length to the surrounding extracellular matrix via the
sarcolemma. The smooth muscle cell sarcolemma is segregated into
domains of rib-like adherens junctions alternating with
regions containing vesicular invaginations (1, 2).
Actin filaments are assembled within the submembranous
adherens junctions or dense plaques, and are coupled to the
sarcolemma via a complex set of molecules; these, in turn, are linked
to the extracellular matrix by transmembrane integrin receptors (3). The "non-junctional" regions are comprised of caveolae which occur in close proximity to Ca2+-storage sites in the
sarcoplasmic reticulum (4, 5). During contraction, the sarcolemma
displays a sequential arrangement of firm, inward-caving anchoring
regions and flexible, outward bulging, hinge-like domains, an
organization which is reminiscent of a barrel when viewed in
three-dimensions (6, 7).
Recently lipid-binding, Ca2+-regulated proteins purified by
us from porcine stomach smooth muscle were identified as belonging to
the annexin protein family. Implicated in membrane organization, these
proteins have also been assigned roles in the regulation of
Ca2+ homeostasis and signal transduction (for review, see
Ref. 8). The purpose of the present study was to pinpoint the
intracellular location of these annexins and to elucidate the mode of
their action in smooth muscle cells. Antibody labeling of thin tissue sections of human taenia coli revealed the intracellular
distribution of annexin VI in smooth muscle to depend upon the
contraction state of the cells. Consequently, our biochemical
experiments revealed the formation of a Ca2+- and
annexin-dependent membrane-cytoskeleton complex. We propose that such a complex is involved in sarcolemmal organization during smooth muscle contraction.
 |
MATERIALS AND METHODS |
Tissue Preparation
Since several of the antibodies employed in this study have a
restricted cross-reactivity, it was necessary to use human material for
immunolabeling. Consent for working with this tissue was obtained from
the Medical-Ethical Commission of the University of Bern.
Thin longitudinal strips of taenia coli were obtained during
surgery or post-mortem, within 12 h of death. These muscle strips were secured at both ends, in a slightly extended state, and then either fixed immediately ("native" tissue) in 4% paraformaldehyde (see below) or plunged into ice-cold Ca2+-free
Na+-Tyrode's solution (140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES, pH 7.4) containing
2 mM EGTA, for periods between 15 min and 12 h to
ensure complete relaxation. Isometric contraction of a number of the
"relaxed" muscle strips (still secured) was elicited by incubation
either in K+-Tyrode's buffer (140 mM KCl, 5 mM NaCl, 1 mM MgCl2, 10 mM glucose, and 10 mM HEPES, pH 7.4) or in
Na+-Tyrode's solution containing 2 mM
CaCl2 and 10 nM angiotensin II, for 1-30 min
in each instance. In some cases, smooth muscle strips were subjected to
contraction-relaxation-contraction cycles. Native, relaxed or
contracted, tissue was fixed in Na+- or
K+-Tyrode's solution containing 4% paraformaldehyde for
2-3 h at ambient temperature. After several washes in
phosphate-buffered saline, muscle strips were cryprotected by immersion
overnight in a polyvinylpyrrolidone/sucrose mixture (9). They were then mounted on aluminum cryopins and plunge-frozen in liquid nitrogen. Semi-thin (~0.25 µM thick) cryosections were prepared
according to the method described by Tokuyasu (10), retrieved on
droplets of 2 M sucrose containing 0.75% gelatin,
transfered to siliconized glass slides, and then maintained in
phosphate-buffered saline for no longer than 1 h prior to immunolabeling.
Immunohistochemistry
Immunolabeling was performed as described by
Jostarndt-Fögen et al. (11). Monoclonal antibodies
against annexins II and VI and a polyclonal antibody against caveolin
were purchased from Transduction Laboratories (Lexington, KY).
Fluorescent labeling was performed using Cy3- or Cy2-conjugated
secondary antibodies (Jackson Laboratories, Baltimore, MD). No
difference in pattern or intensity of staining was observed between
surgically derived material and that obtained up to 12 h
post-mortem. Tissue sections were examined in a Zeiss Axiophot
fluorescent microscope and images collected using a digital CCD camera
(Ultrapix, Astrocam).
Purification of a Smooth Muscle Membrane-Cytoskeleton Complex and
Its Annexin and Lipid Fractions--
Unless otherwise stated, all
procedures were performed at 4 °C or on ice. Minced porcine stomach
muscle (100 g) was extracted in 300 ml of buffer A (60 mM
KCl, 2 mM MgCl2, and 20 mM
imidazol, pH 7.0) containing 0.5% Triton X-100 and 0.2 mM
CaCl2. After centrifugation at 6,000 × g
for 30 min, the supernatant was filtered through glass wool and
subjected to high-speed centrifugation at 50,000 × g
for 90 min. The pellets thereby obtained were washed 3 times (with
intervening centrifugations at 6,000 × g for 30 min)
in 10 volumes of buffer B (120 mM KCl and 20 mM
imidazol, pH 7.0) containing 0.2 mM CaCl2 and
finally resuspended in 10 ml of the same buffer. This represented the
purified membrane-cytoskeleton complex.
For purification of annexin and lipid fractions, the
membrane-cytoskeleton complex was extracted with 5 volumes of buffer B
containing 1 mM EGTA. The extracts were centrifuged at
6,000 × g for 30 min. To the annexin/lipid supernatant
1.2 mM CaCl2 was added. The pellet obtained
after centrifugation at 6,000 × g for 30 min was
washed in buffer B, 0.2 mM CaCl2 (this step led to removal of most of contaminating actin/tropomyosin and
low-Ca2+-sensitive annexin V) and re-extracted with 3 volumes of buffer B containing 1 mM EGTA. The resulting
pellet was washed 3 times (intervening centrifugation 6,000 × g for 30 min) and finally resuspended in buffer B. This
represented the purified lipid fraction of membrane-cytoskeleton
complex. The supernatant was centrifuged at 20,000 × g
for 60 min; the resulting supernatant consisted of the purified annexin
fraction (annexin II and VI). For N-terminal amino acid sequencing,
annexin VI was further purified by anion-exchange chromatography and
gel filtration (Q-Sepharose FF and Sephacryl S-200 HR; Amersham
Pharmacia Biotech, Uppsala, Sweden).
Purification of Smooth Muscle Actomyosin--
As the actomyosin
fraction of the membrane-cytoskeleton complex was contaminated by
lipids, smooth muscle actomyosin was purified according to the method
described by Sobieszek and Bremel (12) for use in recombination
experiments. In short, minced porcine stomach muscle (100 g) was
extracted in 300 ml of buffer A containing 0.5% Triton X-100. The
homogenate was centrifuged at 6,000 × g for 30 min and
the pellet washed 3 times in the same buffer (with intervening
centrifugations at 6,000 × g for 30 min). This was then homogenized in 3 volumes of buffer A containing 2 mM
EDTA, 2 mM EGTA, and 10 mM ATP and the whole
centrifuged at 25,000 × g for 30 min. The supernatant
was filtered through glass wool, and its MgCl2
concentration raised to 25 mM. This fraction was incubated
overnight at 4 °C and then centrifuged at 6,000 × g for 30 min. The resulting pellet was washed extensively in buffer A
containing 1 mM EGTA; it consisted of purified actomyosin.
5'-Nucleotidase Activity--
5'-Nucleotidase was assayed using
5'-AMP as substrate. In brief, samples (2-5 µl) were incubated in
100 mM Tris-HCl (pH 8.5) containing 10 mM AMP
and 10 mM MgCl2 (final volume, 300 µl), for 10-30 min at 37 °C. For control runs, the protein was inactivated prior to incubation by treatment with 5% trichloroacetic acid. The
reaction products were quantified spectrophotometrically
(A820) as described by Parkin et al.
(13).
N-terminal Amino Acid Sequence Analysis and Mass
Spectrometry--
N-terminal amino acid sequence analysis was
performed in a pulsed liquid-phase sequenator 477A (Applied Biosystems)
using the Edman degradation technique and a program adapted from
Hunkapillar et al. (14). The released amino acids were
analyzed on-line by reverse-phase high performance liquid
chromatography. The masses of the samples were determined by
electrospray ionization mass spectrometry using a VG Platform
single-stage quadruple mass spectrometer (Micromass, Manchester, United Kingdom).
SDS-Polyacrylamide Gel Electrophoresis and Western
Blotting--
SDS-PAGE1 was
performed according to the procedure described by Laemmli (15).
Polypeptides were visualized by Coomassie staining. Blotting of gels on
Immobilon-P membranes (Millipore Corp., Bedford, MA) was carried out
according to the method described by Towbin et al. (16).
Monoclonal antibodies against -smooth muscle and -cytoplasmic
actin, smooth muscle myosin, and vinculin were obtained from Sigma.
Immunoreactivity was detected using a secondary antibody conjugated to
horseradish peroxidase (Amersham Pharmacia Biotech) and visualized with diaminobenzidine.
Thin-layer Chromatography (TLC)--
Samples (10-50 µl) were
extracted in a 1:1 mixture (1 ml) of chloroform and methanol for 10 min
on ice. 0.25 ml of water was then added and the emulsion centrifuged
for 5 min. The lower organic layer was carefully removed and dried.
Samples were resuspended in 50 µl of chloroform and spotted onto a
silica gel TLC plate (Merck, Darmstadt, Germany), which was developed
according to Macala et al. (17). Lipid concentration was
estimated by the simultaneous application of lipid standards of known
concentration. Lipids were detected by spraying TLC plates with a 5%
(w/v) ethanolic solution of phosphomolybdic acid, followed by heating
at 120 °C for 10 min.
Miscellaneous--
Protein concentrations were determined
according to the method described by Bradford (18) using bovine serum
albumin as a standard. Free Ca2+ concentrations
([Ca2+]free) were calculated according to
Fabiato and Fabiato (19) and Harrison and Bers (20) using the MAX
CHELATOR computer program designed by Chris Patton (Stanford
University, Hopkins Marine Station).
 |
RESULTS |
Constant changes in the shape of smooth muscle cells during
contraction-relaxation cycles require effective regulatory mechanisms for co-ordinated cytoskeleton and sarcolemma rearrangement to protect
the cells from mechanical damage. It is not inconceivable that these
changes are regulated by calcium-dependent pathways. In our
quest for Ca2+-dependent interactions between
plasma membrane and actin-based cytoskeleton, we were investigating a
redistribution of membrane lipids and actin in smooth muscle extracts
in the presence or absence of Ca2+.
Formation of a Smooth Muscle-specific,
Ca2+-dependent Membrane-Cytoskeleton Complex in
Smooth Muscle Extracts--
Porcine stomach smooth muscle (100 g) was
homogenized in 3 volumes of buffer A in the presence of 2 mM EGTA and the supernatant collected after low-speed
centrifugation (6,000 × g, 30 min) was then subjected
to a high-speed centrifugation (50,000 × g, 90 min) to
remove insoluble material (first high-speed pellet). One-half of the
supernatant was left on ice while to the other 2.2 mM
CaCl2 was added and after incubation of both fractions at
ambient temperature for 30 min they were further centrifuged at
50,000 × g for 90 min. Resulting high-speed
Ca2+ and EGTA pellets as well as the first high-speed
pellet were extensively washed (10,000 × g, 30 min) in
buffer B containing additionally 0.2 mM CaCl2
(Ca2+ pellet) or 1 mM EGTA (EGTA pellet) and
finally resuspended in 10 ml (20 ml for the first high speed pellet) of
buffer B per 0.2 mM CaCl2.
We observed an accumulation of cytoskeletal and contractile elements
( -smooth muscle and -cytoplasmic actin isoforms, smooth muscle
myosin), annexins (II and VI), and membrane lipids in the high-speed
Ca2+ pellet (Fig.
1a and b, lane 4)
in comparison to that obtained in the presence of EGTA (Fig. 1,
a, lanes 5-5', and b, lane 5). Polypeptides of
molecular mass of 32 and 38 kDa present in the Ca2+ pellet
were identified by mass-spectrometry as annexin V and tropomyosin (not
shown).

View larger version (70K):
[in this window]
[in a new window]
|
Fig. 1.
Ca2+-dependent
co-precipitation of actomyosin, membrane lipids, and annexins in smooth
muscle extracts. a and b, equal amounts of
protein (0, 1, 3, 4, 5', 6, and 7) or equal
aliquots (2, 4, and 5) of each sample:
0, 6000 × g pellet; 1, 6000 × g supernatant; 2, first high-speed pellet;
3, first high-speed supernatant; 4, high-speed
Ca2+-pellet; 5, and 5', high-speed
EGTA pellet; 6, high-speed Ca2+-supernatant;
7, high-speed EGTA supernatant, were analyzed for protein
composition by SDS-PAGE (a) or lipid composition by TLC
(b). The positions of major polypeptides identified in
high-speed Ca2+ pellet and cholesterol (Ch),
phosphatidylcholine (PC), phosphatidylethanolamine
(PE), and sphingomyelin (SM) are indicated. Note
an absence of Ca2+- dependent accumulation of calmodulin
(17 kDa) in the Ca2+-pellet (the
Ca2+-independent polypeptide of the same
Mr is myosin light chain). c, the
partial amino acid sequence of rat annexin VI (123-135) is identical
with that of the 67-kDa polypeptide enriched in the Ca2+
pellet. d, Western blotting of Ca2+ pellet
(1-3, 5), 6000 × g pellet (4),
and 50,000 × g Ca2+ supernatant
(6). Equal amounts of protein from each sample were
subjected to SDS-PAGE and blotted with monoclonal antibodies raised
against smooth muscle myosin, (1), -smooth muscle actin
(2), annexin II (3), and -smooth muscle actin
(4-6).
|
|
Incubation of the Ca2+ pellet at 0.47 or 12.2 µM [Ca]free led to separation of both
suspensions into two phases (Fig.
2a). At 0.47 [Ca]free lipids were evenly distributed over the total
volume, while actomyosin formed the lower phase. At 12.2 µM [Ca]free, the smaller upper phase did
not contain lipids nor actomyosin, both of which constituted the lower
phase (Fig. 2a). At elevated [Ca2+]free, the recombination of the lipid
and annexin fractions of the Ca2+ pellet with purified
actomyosin (Fig. 2b), led to the formation of a structured
precipitate, identical to that shown in Fig. 2a. At low
[Ca2+]free or in the absence of either
annexin or lipid fractions, actomyosin rapidly accumulated at the
bottom of the tube (see Fig. 2b). Thus, both lipid and
annexin fractions are responsible for the
Ca2+-dependent changes in actomyosin
precipitation pattern. This observation, in concert with the
Ca2+-dependent co-fractionation of actomyosin,
annexins, and lipids in smooth muscle extracts (Fig. 1) suggested the
formation of a lipid-annexin-actomyosin (membrane-cytoskeleton) complex
at elevated Ca2+ concentrations. The Ca2+
sensitivity of this complex formation (Fig. 2b) corresponded to that of annexin II and VI binding within the complex (Fig. 2c), suggesting that these proteins act as
Ca2+-sensitive linkers between actomyosin
(actin-based cytoskeleton) and lipids (sarcolemma).

View larger version (80K):
[in this window]
[in a new window]
|
Fig. 2.
Ca2+- and
annexin-dependent formation of a membrane-cytoskeleton
complex. a, suspensions of the Ca2+ pellet
(1.5 mg/ml protein) were incubated for 60 min on ice in buffer B at
0.47 (1) or 12.2 (2) µM
[Ca]free. 50 µM of each upper
(U) and lower (L) phases were withdrawn and equal
aliquots analyzed by SDS-PAGE and TLC. b, purified
actomyosin (100 µg) was recombined (final volume: 50 µl) either
with the purified annexin fraction (25 µg) (Anx + AM), the
purified lipid fraction (50 µg) (Lip + AM), or both
annexin, and lipid fractions (Anx + Lip + AM), at the
indicated concentrations of free Ca2+. After incubation for
20 min on ice the fractions separated into 2 phases, as shown in
a. Subsequently, 30-µl aliquots were carefully withdrawn
from the top of each sample and analyzed by SDS-PAGE. The
volume of the lower phase increases in parallel with the increase in
Ca2+ concentration due to formation of a structured
precipitate (as shown in a). Therefore, at rising
Ca2+ concentrations, the analyzed samples (b)
contain a higher proportion of proteins present in the lower phase.
Note the absence of calmodulin (molecular mass = 17 kDa) in the
annexin or lipid fractions. c, the Ca2+ pellet
was resuspended in buffer B containing 1 mM EGTA, and
supplemented with EGTA/CaCl2 to obtain the indicated final
concentrations of [Ca2+]free
(µM), final protein concentration being 1.5 mg/ml. After
incubation for 15 min at ambient temperature, the suspension was
separated by centrifugation at 6,000 × g for 30 min,
and equal aliquots of supernatant analyzed by SDS-PAGE. The positions
of annexins II (mass = 34 kDa) and VI (mass = 67 kDa) are
indicated. Note that annexin V was the least Ca2+-sensitive
among the annexins and required unphysiologically high concentrations
of Ca2+ for its binding within the complex.
|
|
Detailed analysis of the lipid composition revealed that the lipid
fraction of the Ca2+ pellet was enriched in cholesterol and
sphingomyelin (Fig. 1b) properties attributed to the
so-called "detergent insoluble glycosphingolipid-enriched membrane
domains," characteristic for caveolae (21). In addition, these
structures contain glycosylphosphatidylinositol-anchored proteins
(i.e. 5'-nucleotidase) (21). Western blotting and
5'-nucleotidase activity measurements demonstrated that in contrast to
vinculin, a specific marker for adherens junctions, both
caveolar-specific marker proteins, caveolin and 5'-nucleotidase, were
enriched in the Ca2+ pellet (Fig.
3, a and b).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 3.
The caveolar domain of smooth muscle
sarcolemma is a component of the membrane-cytoskeleton complex.
Samples prepared and numbered as described in the legend to Fig. 1 were
analyzed by Western blotting for caveolin and vinculin (a)
or by measurement of specific enzymatic activity for 5'-nucleotidase
(b) contents.
|
|
A comparative study, performed on smooth, skeletal, and cardiac
muscle extracts points to the specificity of the membrane-cytoskeleton complex for smooth muscle (Fig. 4).
Neither the annexins, nor actomyosin were present in skeletal or heart
muscle high speed pellets (Fig. 4a). Besides,
5'-nucleotidase activity and an elevated cholesterol, sphingomyelin
contents were observed exclusively in smooth muscle samples (Fig. 4,
b and c).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 4.
The membrane-cytoskeleton complex is specific
for smooth muscle. High-speed Ca2+ pellets (1, 3, and 5) were obtained from skeletal (1),
cardiac (3), and smooth (5) muscle as described
under "Materials and Methods." The corresponding high-speed EGTA
pellets (2, 4, and 6) were obtained by the same
procedure except that CaCl2 in the initial extracts was
substituted by 1 mM EGTA. Equal aliquots of each resulting
pellet were analyzed for protein (SDS-PAGE) (a) and lipid
(TLC) composition (b) and for 5'-nucleotidase activity
(c).
|
|
Annexin VI Translocates to the Sarcolemma in Response to
Ca2+ Elevation--
In agreement with Ca2+
-dependent translocation of annexin VI observed in
biochemical experiments its distribution in smooth muscle cells
depended upon their state of contraction. When fixed in rigor (native
tissue), this protein was located exclusively within the plasmalemma
(Fig. 5a). After relaxation of
cells in a Ca2+ free solution for periods between 15 min
and 12 h, annexin VI became diffusely distributed within the
cytosol (Fig. 5b). Subsequent incubation of this relaxed
muscle in a contraction solution, prompted relocation of annexin VI to
the plasmalemma (Fig. 5c). Stimulation of muscle strips
which had been maintained in a relaxed state for longer than 12 h
led to an increasingly patchy plasmalemmal staining for annexin VI,
which was accompanied by enhanced labeling of the nuclear lamina and
spotted cytosol (Fig. 5d). The low intensity of staining of
annexin II in smooth muscle cells rendered difficult an assessment of
its potential redistribution during contraction.

View larger version (162K):
[in this window]
[in a new window]
|
Fig. 5.
Redistribution of annexin VI in smooth muscle
cells during contraction-relaxation cycles. Transverse sections of
human taenia coli double-labeled with antibodies against
annexin VI (a, c, e, and g) and caveolin
((b, d, f, and h) for the demarcation of cell
borders). Within smooth muscle cells fixed in rigor
(a and b), annexin VI is localized to the
plasmalemma (a): after relaxation of cells for 2 h,
this protein becomes diffusely distributed (c).
Depolarization of the sarcolemma (with ensuing cell contraction),
elicits a reversion to the plasmalemmal localization of annexin VI
(e). Incubation of cells in the relaxing solution for longer
than 12 h renders the plasma membranes leaky. Subsequent
stimulation of such cells leads to more sporadic plasmalemmal labeling
for annexin VI and an increased frequency of stained nuclear laminae
(g) (arrowheads). Bar = 20 µm.
|
|
 |
DISCUSSION |
Annexins II and VI Act as Ca2+-sensitive Linkers
between the Caveolar Domain of the Sarcolemma and the Actin-based
Cytoskeleton--
The mechanical link coupling cytoskeletal and
contractile proteins to the sarcolemma of smooth muscle cells is
essential for transmitting tension from the cell's interior to the
exterior. The sarcolemma is segregated into regularly spaced domains of rib-like adherens junctions alternating with caveolae
containing regions (1, 2). In adherens junctions or
plasmalemma-associated dense plaques, actin filaments are coupled to
transmembrane integrins via a cascade of submembranous proteins. While
the mechanisms regulating the assembly of dense plaques are still the
subject of intense investigation, it is generally taken for granted
that these structures exist in a fixed, assembled state throughout the
entire contraction-relaxation cycle.
Our work postulates on the existence of an additional, and reversible,
cytoskeleton-membrane complex, which is forged in the caveolar domain
of the sarcolemma in response to a rise in Ca2+
concentration following smooth muscle cell stimulation. The
Ca2+ sensitivity of this complex indicates that it can be
formed in vivo under the conditions prevailing during smooth
muscle contraction (22).
The plasmalemmal sites are obvious loci for the formation of such
reversible, cytoskeletal links, since the plasmalemma is closely
apposed to cytoskeletal elements. Apart from the adherens junction, known to serve as attachment site for the actin filaments, actin and myosin subfragment 1 have been identified in fractions of
purified caveolae (23-26) and the caveolar-specific plasmalemmal inositol 1,4,5-triphosphate receptor-like protein is aligned along actin filaments in bovine aortic endothelial cells (27). In addition,
annexins II and VI were found to be components of different membranous
preparations, usually also containing significant amounts of actin (24,
25, 28, 29).
The particular distribution of membrane domain markers such as caveolin
and 5'-nucleotidase, together with high amounts of cholesterol and
sphingomyelin in the Ca2+ pellet, suggests that the
caveolar domain of the sarcolemma takes part in the formation of the
Ca2+-regulated membrane-cytoskeleton complex. In agreement
with these data, the Ca2+ pellet did not include vinculin,
the main component of the adherens junctions.
A property shared by all members of the annexin protein family is their
capacity to bind acidic phospholipids and actin-based cytoskeletal
elements in a Ca2+-dependent manner (30-36).
These characteristics render them ideal candidates to play a role as
Ca2+-sensitive linkers between the cell's membranous
structures and cytoskeleton. However, while the well documented
interactions between annexins and acidic phospholipids or actin-based
cytoskeletal elements could play a role in formation of the
membrane-cytoskeleton complex described here, the precise mechanisms
responsible have not been elucidated to date.
The Redistribution of Annexins in Response to Stimulation of Smooth
Muscle Cells--
Even in unstimulated cells, the localization of
annexins and their precise allocation to a distinct intracellular
compartment remain a subject of controversy (for reviews, see Refs. 8
and 37). Observations concerning the translocation of annexins in stimulated cells are thus often contradictory. These apparent contradictions reflect the great complexity and diversification of the
responses to stimulation manifested by different cell and tissue types
and the multitude of different annexins present within a given cell
(36, 38). Discrepancies can also be accounted for by the developmental
state of a cell or by experimental variables, such as fixation, type of
antibody used, or the duration of stimulation (39). Therefore, it is
not surprising that, while Kaufman et al. (40) ascribed the
translocation of annexin I from the cytosol of resting neutrophils to
the plasma membrane to a rise in intracellular Ca2+
concentration, Raynal et al. (41), on the other hand,
demonstrated that in human fibroblasts annexins I, II, VI, and VII do
not redistribute during treatment with the Ca2+ ionophore
A23187. And in myogenic cell lines, as well as in human fibroblasts,
annexins II, IV, V, VI, or VII have been shown to relocate to the
plasma membrane, endoplasmic reticulum, cytoplasmic vesicles, or other
intracellular membranes, in response to rises in Ca2+
concentration (39, 41, 42).
In our study, human smooth muscle of surgical or autoptic origin was
always in a state of rigor upon our receipt of it, this being recognized by the plasmalemmal localization of annexin VI's. After inducing relaxation by incubation in an EGTA-containing solution,
a diffuse redistribution of annexin VI to the cytosol was observed. In
the only previous investigation, annexin VI has been localized to the
sarcolemma of smooth muscle cells indicating that the tissue the
authors used for their study was fixed in the state of rigor
(43). In the present paper we, for the first time, demonstrate that
stimulation of smooth muscle led to a rapid and reversible relocation
of annexin VI from the cytosol to the plasma. However, if smooth muscle
was relaxed for periods longer than ~12 h prior to contraction or
subjected to repeated contraction-relaxation cycles, annexin VI
labeling of the plasmalemma became increasingly patchy and the number
of cells revealed a nuclear laminal signal. We ascribe this
increasingly irregular pattern of redistribution in patches of
irregular size and distribution to a gradual decay in plasmalemmal
integrity, with an accompanying increase in Ca2+ influx and
spurious binding of annexin VI to detached lipid-membrane structures.
Annexin II, a vigorously investigated member of this protein
family, was indeed but scantily stained in smooth muscle cells with
available antibody making difficult an assessment of its potential
redistribution during contraction. However, our biochemical data
suggest that a relocation of annexin II could, indeed, take place upon
smooth muscle stimulation. Other authors have reported such a
relocation to occur (from cytoplasmic to membrane sites) after
stimulation of a number of cell types (42, 44-47).
In conclusion, we suggest that annexins II and VI play a determinant
role in smooth muscle contraction and sarcolemmal organization providing a Ca2+-sensitive link between sarcolemma
and underlying actin-based cytoskeleton. A physiological function for
such a link would be a co-operative regulation of cytoskeleton and
plasmalemma rearrangements during contraction-relaxation cycles to
prevent the cell membrane from mechanical damage and to ensure a better
force transduction from contractile apparatus to extracellular matrix.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Johannes Schittny for help with
image processing, Dr. Ceri England for critical reading of the
manuscript, Dr. Peter Bütikofer for help and advice, and Prof. T. Schaffner and Prof. M. Büchler for the donation of autoptic and
surgical tissue. The excellent technical and photographic assistance of
Catherine Allemann-Probst and Barbara Krieger, respectively, is
gratefully acknowledged.
 |
FOOTNOTES |
*
This work was supported by Swiss National Science Foundation
Grants 30'31-44'379.95 and 31-57071.99 and Roche Foundation Grant 97-223.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
 |
ABBREVIATIONS |
The abbreviation used is:
PAGE, polyacrylamide
gel electorphoresis.
 |
REFERENCES |
| 1.
|
Draeger, A.,
Stelzer, E. H. K.,
Herzog, M.,
and Small, J. V.
(1989)
J. Cell Sci.
94,
703-711[Abstract/Free Full Text]
|
| 2.
|
Ehler, E.,
Babiychuk, E.,
and Draeger, A.
(1996)
Cell Motil. Cytoskeleton
34,
288-298[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Burridge, K.,
Fath, K.,
Kelly, G.,
Nuckolls, C.,
and Turner, C.
(1988)
Ann. Rev. Cell Biol.
4,
487-525[CrossRef]
|
| 4.
|
Gabella, G.
(1976)
Cell Tissue Res.
170,
187-201[Medline]
[Order article via Infotrieve]
|
| 5.
|
Villa, A.,
Podini, P.,
Panzeri, M. C.,
Soling, H. D.,
Volpe, P.,
and Meldolesi, J.
(1993)
J. Cell Biol.
121,
1041-1051[Abstract/Free Full Text]
|
| 6.
|
Small, J. V.,
Fürst, D. O.,
and Thornell, L. E.
(1992)
Eur. J. Biochem.
208,
559-572[Medline]
[Order article via Infotrieve]
|
| 7.
|
Small, J. V.
(1995)
BioEssays
17,
785-792[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Gerke, V.,
and Moss, S. E.
(1997)
Biochim. Biophys. Acta Mol. Cell Res.
1357,
129-154[Medline]
[Order article via Infotrieve]
|
| 9.
|
Tokuyasu, K. T.
(1989)
Histochem. J.
21,
163-171[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Tokuyasu, K. T.
(1980)
Histochem. J.
12,
381-403[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Jostarndt-Fögen, K.,
Djonov, V.,
and Draeger, A.
(1998)
Histochem. Cell Biol.
110,
273-284[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Sobieszek, A.,
and Bremel, R. D.
(1975)
Eur. J. Biochem.
55,
49-60[Medline]
[Order article via Infotrieve]
|
| 13.
|
Parkin, E. T.,
Turner, A. J.,
and Hooper, N. M.
(1996)
Biochem. J.
319,
887-896
|
| 14.
|
Hunkapillar, M. W.,
Hewick, R.,
Dreyer, W.,
and Hood, L.
(1983)
Methods Enzymol.
91,
399-413[Medline]
[Order article via Infotrieve]
|
| 15.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 16.
|
Towbin, H. T.,
Staehelin, J.,
and Gordon, J.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
4350-4354[Abstract/Free Full Text]
|
| 17.
|
Macala, L. J., Yu, R. K.,
and Ando, S.
(1983)
J. Lipid Res.
24,
1243-1250[Abstract]
|
| 18.
|
Bradford, M. M.
(1976)
Anal. Biochem.
72,
248-254[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Fabiato, A.,
and Fabiato, F.
(1979)
J. Physiol. (Paris)
75,
463-505[Medline]
[Order article via Infotrieve]
|
| 20.
|
Harrison, S. M.,
and Bers, D. M.
(1989)
Am. J. Physiol.
256,
C1250-C1256[Abstract/Free Full Text]
|
| 21.
|
Schnitzer, J. E.,
McIntosh, D. P.,
Dvorak, A. M.,
Liu, J.,
and Oh, P.
(1995)
Science
269,
1435-1439[Abstract/Free Full Text]
|
| 22.
|
Hartshorne, D. J.
(1987)
in
Physiology of the Gastrointestinal Tract
(Johnson, L. R., ed)
, pp. 423-481, Raven Press, New York
|
| 23.
|
Izumi, T.,
Shibata, Y.,
and Yamamoto, T.
(1988)
Anat. Rec.
220,
225-232[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Chang, W. J.,
Ying, Y. S.,
Rothberg, K. G.,
Hooper, N. M.,
Turner, A. J.,
Gambliel, H. A.,
De Gunzburg, J.,
Mumby, S. M.,
Gilman, A. G.,
and Anderson, R. G.
(1994)
J. Cell Biol.
126,
127-138[Abstract/Free Full Text]
|
| 25.
|
Lisanti, M. P.,
Scherer, P. E.,
Vidugiriene, J.,
Tang, Z.,
Hermanowski-Vosatka, A.,
Tu, Y. H.,
Cook, R. F.,
and Sargiacomo, M.
(1994)
J. Cell Biol.
126,
111-126[Abstract/Free Full Text]
|
| 26.
|
Smart, E. J.,
Ying, Y. S.,
Mineo, C.,
and Anderson, R. G.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10104-10108[Abstract/Free Full Text]
|
| 27.
|
Fujimoto, T.,
Nakade, S.,
Miyawaki, A.,
Mikoshiba, K.,
and Ogawa, K.
(1992)
J. Cell Biol.
119,
1507-1513[Abstract/Free Full Text]
|
| 28.
|
Parkin, E. T.,
Turner, A. J.,
and Hooper, N. M.
(1996)
Biochem. J.
319,
887-896
|
| 29.
|
Stan, R. V.,
Roberts, W. G.,
Predescu, D.,
Ihida, K.,
Saucan, L.,
Ghitescu, L.,
and Palade, G. E.
(1997)
Mol. Biol. Cell
8,
595-605[Abstract]
|
| 30.
|
Gerke, V.,
and Weber, K.
(1984)
EMBO J.
3,
227-233[Medline]
[Order article via Infotrieve]
|
| 31.
|
Glenney, J.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
4258-4262[Abstract/Free Full Text]
|
| 32.
|
Glenney, J. R. J.,
Tack, B.,
and Powell, M. A.
(1987)
J. Cell Biol.
104,
503-511[Abstract/Free Full Text]
|
| 33.
|
Ikebuchi, N. W.,
and Waisman, D. M.
(1990)
J. Biol. Chem.
265,
3392-3400[Abstract/Free Full Text]
|
| 34.
|
Hosoya, H.,
Kobayashi, R.,
Tsukita, S.,
and Matsumura, F.
(1992)
Cell Motil. Cytoskeleton
22,
200-210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Diakonova, M.,
Gerke, V.,
Ernst, J.,
Liautard, J. P.,
van der Vusse, G.,
and Griffiths, G.
(1997)
J. Cell Sci.
110,
1199-1213[Abstract]
|
| 36.
|
Raynal, P.,
Pollard, H. B.,
and Srivastava, M.
(1997)
Biochem. J.
322,
365-371
|
| 37.
|
Raynal, P.,
and Pollard, H. B.
(1994)
Biochim. Biophys. Acta
1197,
63-93[Medline]
[Order article via Infotrieve]
|
| 38.
|
Massey-Harroche, D.,
Mayran, N.,
and Maroux, S.
(1998)
J. Cell Sci.
111,
3007-3015[Abstract]
|
| 39.
|
Selbert, S.,
Fischer, P.,
Menke, A.,
Jockusch, H.,
Pongratz, D.,
and Noegel, A. A.
(1996)
Exp. Cell Res.
222,
199-208[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Kaufman, M.,
Leto, T.,
and Levy, R.
(1996)
Biochem. J.
316,
35-42
|
| 41.
|
Raynal, P.,
Kuijpers, G.,
Rojas, E.,
and Pollard, H. B.
(1996)
FEBS Lett.
392,
263-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Barwise, J. L.,
and Walker, J. H.
(1996)
FEBS Lett.
394,
213-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Iida, H.,
Hatae, T.,
and Shibata, Y.
(1992)
J. Histochem. Cytochem.
40,
1899-1907[Abstract]
|
| 44.
|
Blanchard, S.,
Barwise, J. L.,
Gerke, V.,
Goodall, A.,
Vaughan, P. F.,
and Walker, J. H.
(1996)
J. Neurochem.
67,
805-813[Medline]
[Order article via Infotrieve]
|
| 45.
|
Chasserot-Golaz, S.,
Vitale, N.,
Sagot, I.,
Delouche, B.,
Dirrig, S.,
Pradel, L. A.,
Henry, J. P.,
Aunis, D.,
and Bader, M. F.
(1996)
J. Cell Biol.
133,
1217-1236[Abstract/Free Full Text]
|
| 46.
|
Kang, S. A.,
Cho, Y. J.,
Moon, H. B.,
and Na, D. S.
(1996)
Br. J. Pharmacol.
117,
1780-1784[Medline]
[Order article via Infotrieve]
|
| 47.
|
Sagot, I.,
Regnouf, F.,
Henry, J. P.,
and Pradel, L. A.
(1997)
FEBS Lett.
410,
229-234[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
K. Monastyrskaya, E. B. Babiychuk, A. Hostettler, P. Wood, T. Grewal, and A. Draeger
Plasma Membrane-associated Annexin A6 Reduces Ca2+ Entry by Stabilizing the Cortical Actin Cytoskeleton
J. Biol. Chem.,
June 19, 2009;
284(25):
17227 - 17242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Genge, L. N. Y. Wu, and R. E. Wuthier
In Vitro Modeling of Matrix Vesicle Nucleation: SYNERGISTIC STIMULATION OF MINERAL FORMATION BY ANNEXIN A5 AND PHOSPHATIDYLSERINE
J. Biol. Chem.,
September 7, 2007;
282(36):
26035 - 26045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Zhang and W. X. Wu
Separate and synergistic effect of progesterone and estradiol on induction of annexin 2 and its interaction protein p11 in pregnant sheep myometrium
J. Mol. Endocrinol.,
April 1, 2007;
38(4):
441 - 454.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Chang, C. Sutherland, E. Hesse, R. Winkfein, W. B. Wiehler, M. Pho, C. Veillette, S. Li, D. P. Wilson, E. Kiss, et al.
Identification of a novel interaction between the Ca2+-binding protein S100A11 and the Ca2+- and phospholipid-binding protein annexin A6
Am J Physiol Cell Physiol,
April 1, 2007;
292(4):
C1417 - C1430.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Burlak, A. R. Whitney, D. J. Mead, T. Hackstadt, and F. R. DeLeo
Maturation of Human Neutrophil Phagosomes Includes Incorporation of Molecular Chaperones and Endoplasmic Reticulum Quality Control Machinery
Mol. Cell. Proteomics,
April 1, 2006;
5(4):
620 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.-M. Ka, A. Rifai, J.-H. Chen, C.-W. Cheng, H.-A. Shui, H.-S. Lee, Y.-F. Lin, L.-F. Hsu, and A. Chen
Glomerular crescent-related biomarkers in a murine model of chronic graft versus host disease
Nephrol. Dial. Transplant.,
February 1, 2006;
21(2):
288 - 298.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. D. Smith, E. B. Babiychuk, K. Noble, A. Draeger, and S. Wray
Increased cholesterol decreases uterine activity: functional effects of cholesterol alteration in pregnant rat myometrium
Am J Physiol Cell Physiol,
May 1, 2005;
288(5):
C982 - C988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Camors, V. Monceau, and D. Charlemagne
Annexins and Ca2+ handling in the heart
Cardiovasc Res,
March 1, 2005;
65(4):
793 - 802.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Monastyrskaya, A. Hostettler, S. Buergi, and A. Draeger
The NK1 Receptor Localizes to the Plasma Membrane Microdomains, and Its Activation Is Dependent on Lipid Raft Integrity
J. Biol. Chem.,
February 25, 2005;
280(8):
7135 - 7146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Riquelme, P. Llanos, E. Tischner, J. Neil, and B. Campos
Annexin 6 Modulates the Maxi-chloride Channel of the Apical Membrane of Syncytiotrophoblast Isolated from Human Placenta
J. Biol. Chem.,
November 26, 2004;
279(48):
50601 - 50608.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. t. Vruchte, E. Lloyd-Evans, R. J. Veldman, D. C. A. Neville, R. A. Dwek, F. M. Platt, W. J. van Blitterswijk, and D. J. Sillence
Accumulation of Glycosphingolipids in Niemann-Pick C Disease Disrupts Endosomal Transport
J. Biol. Chem.,
June 18, 2004;
279(25):
26167 - 26175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. H. Thomas, K. M. Kaspar, W. B. Taft, N. Weng, L. A. Rodenkirch, and G. E. Groblewski
Identification of Annexin VI as a Ca2+-sensitive CRHSP-28-binding Protein in Pancreatic Acinar Cells
J. Biol. Chem.,
September 13, 2002;
277(38):
35496 - 35502.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Moga and D. Zhou
Annexin 6 Immunoreactivity in Select Cell Populations in the Rat Brain
J. Histochem. Cytochem.,
September 1, 2002;
50(9):
1277 - 1280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. de Diego, F. Schwartz, H. Siegfried, P. Dauterstedt, J. Heeren, U. Beisiegel, C. Enrich, and T. Grewal
Cholesterol Modulates the Membrane Binding and Intracellular Distribution of Annexin 6
J. Biol. Chem.,
August 23, 2002;
277(35):
32187 - 32194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Takagi, Y. Asano, N. Yamakawa, I. Matsumoto, and K. Kimata
Annexin 6 is a putative cell surface receptor for chondroitin sulfate chains
J. Cell Sci.,
August 15, 2002;
115(16):
3309 - 3318.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. BABIYCHUK, K. MONASTYRSKAYA, F. C. BURKHARD, S. WRAY, and A. DRAEGER
Modulating signaling events in smooth muscle: cleavage of annexin 2 abolishes its binding to lipid rafts
FASEB J,
August 1, 2002;
16(10):
1177 - 1184.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gerke and S. E. Moss
Annexins: From Structure to Function
Physiol Rev,
April 1, 2002;
82(2):
331 - 371.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. B. Babiychuk and A. Draeger
Annexins in Cell Membrane Dynamics: Ca2+-regulated Association of Lipid Microdomains
J. Cell Biol.,
September 5, 2000;
150(5):
1113 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Grewal, J. Heeren, D. Mewawala, T. Schnitgerhans, D. Wendt, G. Salomon, C. Enrich, U. Beisiegel, and S. Jackle
Annexin VI Stimulates Endocytosis and Is Involved in the Trafficking of Low Density Lipoprotein to the Prelysosomal Compartment
J. Biol. Chem.,
October 20, 2000;
275(43):
33806 - 33813.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|